Immunoprecise Stock Technical Analysis

IPA -  USA Stock  

USD 5.30  0.15  2.75%

As of the 28th of May, Immunoprecise Antibodies retains the Market Risk Adjusted Performance of 0.2381, downside deviation of 4.13, and Risk Adjusted Performance of 0.0765. Immunoprecise Antibodies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Immunoprecise Antibodies, which can be compared to its competitors. Please check out Immunoprecise Antibodies maximum drawdown, and the relationship between the information ratio and downside variance to decide if Immunoprecise Antibodies is priced fairly, providing market reflects its last-minute price of 5.3 per share. Given that Immunoprecise Antibodies has jensen alpha of 0.2311, we strongly advise you to confirm Immunoprecise Antibodies's regular market performance to make sure the company can sustain itself at a future point.

Immunoprecise Antibodies Analyst Consensus

Target PriceAdvice# of Analysts
12.0Strong Buy1Odds
Immunoprecise Antibodies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Immunoprecise analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunoprecise stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunoprecise Antibodies, talking to its executives and customers, or listening to Immunoprecise conference calls.
Immunoprecise Analyst Advice Details
Immunoprecise Antibodies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunoprecise Antibodies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunoprecise Antibodies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Immunoprecise Antibodies Technical Analysis

The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Immunoprecise Antibodies volatility developed by Welles Wilder.

Immunoprecise Antibodies Trend Analysis

Use this graph to draw trend lines for Immunoprecise Antibodies. You can use it to identify possible trend reversals for Immunoprecise Antibodies as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Immunoprecise Antibodies price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Immunoprecise Antibodies Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Immunoprecise Antibodies applied against its price change over selected period. The best fit line has a slop of   0.017146  , which may imply that Immunoprecise Antibodies will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 11.12, which is the sum of squared deviations for the predicted Immunoprecise Antibodies price change compared to its average price change.

About Immunoprecise Antibodies Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunoprecise Antibodies on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunoprecise Antibodies based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunoprecise Antibodies stock first instead of the macroeconomic environment surrounding Immunoprecise Antibodies. By analyzing Immunoprecise Antibodies's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunoprecise Antibodies's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunoprecise Antibodies specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2020 2021 2022 (projected)
Book Value per Share3.463.973.25
Asset Turnover0.380.340.36

Immunoprecise Antibodies May 28, 2022 Technical Indicators

Most technical analysis of Immunoprecise help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunoprecise from various momentum indicators to cycle indicators. When you analyze Immunoprecise charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.